Drew C. Deniger

2.2k total citations
18 papers, 1.2k citations indexed

About

Drew C. Deniger is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Drew C. Deniger has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Drew C. Deniger's work include CAR-T cell therapy research (16 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). Drew C. Deniger is often cited by papers focused on CAR-T cell therapy research (16 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). Drew C. Deniger collaborates with scholars based in United States, Malaysia and Israel. Drew C. Deniger's co-authors include Steven A. Rosenberg, Anna Pasetto, Paul F. Robbins, Lee Jia, Laurence J.N. Cooper, Jared J. Gartner, Maria R. Parkhurst, Biman C. Paria, Judy S. Moyes and Parisa Malekzadeh and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Drew C. Deniger

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Drew C. Deniger United States 14 874 737 302 166 98 18 1.2k
Elixabet Bolaños Spain 19 887 1.0× 972 1.3× 290 1.0× 146 0.9× 80 0.8× 33 1.4k
Wouter Scheper Netherlands 11 773 0.9× 924 1.3× 310 1.0× 69 0.4× 95 1.0× 15 1.3k
Remko Schotte Netherlands 14 923 1.1× 1.4k 1.9× 468 1.5× 133 0.8× 99 1.0× 23 1.8k
Smita S. Chandran United States 13 670 0.8× 682 0.9× 261 0.9× 131 0.8× 57 0.6× 19 1.0k
Daniel Hirschhorn-Cymerman United States 15 979 1.1× 1.4k 1.9× 272 0.9× 87 0.5× 74 0.8× 22 1.7k
Sarah L. Buchan United Kingdom 18 434 0.5× 829 1.1× 392 1.3× 102 0.6× 81 0.8× 26 1.1k
Marjolein Sluijter Netherlands 21 768 0.9× 1.2k 1.6× 364 1.2× 60 0.4× 119 1.2× 38 1.5k
Rieneke van de Ven Netherlands 23 770 0.9× 876 1.2× 404 1.3× 74 0.4× 43 0.4× 61 1.4k
Toshiaki Yoshikawa Japan 21 676 0.8× 752 1.0× 564 1.9× 84 0.5× 108 1.1× 54 1.4k
Annette Arnold Germany 12 522 0.6× 827 1.1× 262 0.9× 198 1.2× 45 0.5× 17 1.2k

Countries citing papers authored by Drew C. Deniger

Since Specialization
Citations

This map shows the geographic impact of Drew C. Deniger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew C. Deniger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew C. Deniger more than expected).

Fields of papers citing papers by Drew C. Deniger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drew C. Deniger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew C. Deniger. The network helps show where Drew C. Deniger may publish in the future.

Co-authorship network of co-authors of Drew C. Deniger

This figure shows the co-authorship network connecting the top 25 collaborators of Drew C. Deniger. A scholar is included among the top collaborators of Drew C. Deniger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Drew C. Deniger. Drew C. Deniger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Morelli, Maria Pia, Marcelo V. Negrão, Matthew R. Collinson-Pautz, et al.. (2023). Safety and efficacy of Sleeping Beauty TCR-T cells targeting shared KRAS and TP53 mutations expressed by solid tumors in first-in-human phase 1 study.. Journal of Clinical Oncology. 41(16_suppl). 2547–2547. 6 indexed citations
2.
Paria, Biman C., Noam Levin, Frank J. Lowery, et al.. (2020). Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single Cells. Journal of Immunotherapy. 44(1). 1–8. 21 indexed citations
3.
Lo, Winifred, Maria R. Parkhurst, Paul F. Robbins, et al.. (2019). Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer. Cancer Immunology Research. 7(4). 534–543. 105 indexed citations
4.
Malekzadeh, Parisa, Anna Pasetto, Paul F. Robbins, et al.. (2019). Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers. Journal of Clinical Investigation. 129(3). 1109–1114. 197 indexed citations
5.
Cafri, Gal, Rami Yossef, Anna Pasetto, et al.. (2019). Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients. Nature Communications. 10(1). 449–449. 112 indexed citations
6.
Ahmadzadeh, Mojgan, Anna Pasetto, Lee Jia, et al.. (2019). Tumor-infiltrating human CD4 + regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity. Science Immunology. 4(31). 156 indexed citations
7.
Deniger, Drew C., Anna Pasetto, Paul F. Robbins, et al.. (2018). T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers. Clinical Cancer Research. 24(22). 5562–5573. 110 indexed citations
8.
Deniger, Drew C., Anna Pasetto, Eric Tran, et al.. (2016). Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System. Molecular Therapy. 24(6). 1078–1089. 54 indexed citations
9.
Thokala, Radhika, Simon Olivares, Tiejuan Mi, et al.. (2016). Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors. PLoS ONE. 11(8). e0159477–e0159477. 51 indexed citations
10.
Deniger, Drew C., Anna Pasetto, Todd D. Prickett, et al.. (2016). 391. Mutated Tumor Neoantigens Are Recognized by Tumor Infiltrating Lymphocytes from Metastatic Ovarian Cancer. Molecular Therapy. 24. S155–S155. 2 indexed citations
11.
Deniger, Drew C., Mei Li M. Kwong, Anna Pasetto, et al.. (2016). A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma. Clinical Cancer Research. 23(2). 351–362. 45 indexed citations
12.
Deniger, Drew C., Jianqiang Yu, M. Helen Huls, et al.. (2015). Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations. PLoS ONE. 10(6). e0128151–e0128151. 44 indexed citations
13.
Pasetto, Anna, Drew C. Deniger, Ken‐ichi Hanada, et al.. (2015). Tetramer based approach for efficient identification and isolation of neo-antigen specific CD8 T cells from peripheral blood (PBL) of patients with metastatic cancers. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P47–P47. 3 indexed citations
14.
Pasetto, Anna, Alena Gros, Paul F. Robbins, et al.. (2015). High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity. Journal for ImmunoTherapy of Cancer. 3(S2). 1 indexed citations
15.
Deniger, Drew C., Sourindra N. Maiti, Tiejuan Mi, et al.. (2014). Activating and Propagating Polyclonal Gamma Delta T Cells with Broad Specificity for Malignancies. Clinical Cancer Research. 20(22). 5708–5719. 104 indexed citations
16.
Deniger, Drew C., Judy S. Moyes, & Laurence J.N. Cooper. (2014). Clinical Applications of Gamma Delta T Cells with Multivalent Immunity. Frontiers in Immunology. 5. 636–636. 83 indexed citations
17.
Kolokoltsov, Andrey A., et al.. (2007). Small Interfering RNA Profiling Reveals Key Role of Clathrin-Mediated Endocytosis and Early Endosome Formation for Infection by Respiratory Syncytial Virus. Journal of Virology. 81(14). 7786–7800. 86 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elixabet Bolaños Breakdown of academic impact, for papers by Wouter Scheper Breakdown of academic impact, for papers by Remko Schotte Breakdown of academic impact, for papers by Smita S. Chandran Breakdown of academic impact, for papers by Daniel Hirschhorn-Cymerman Breakdown of academic impact, for papers by Sarah L. Buchan Breakdown of academic impact, for papers by Marjolein Sluijter Breakdown of academic impact, for papers by Rieneke van de Ven Breakdown of academic impact, for papers by Toshiaki Yoshikawa Breakdown of academic impact, for papers by Annette Arnold
Rankless by CCL
2026